RS
GSK icon

Rakuten Securities’s GSK GSK Stock Holding History

Rakuten Securities’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$315 Buy
6
+1
+20% +$53 ﹤0.01% 807
2026
Q1 		$276 Hold
5
– – ﹤0.01% 782
2025
Q4 		$245 Sell
5
-4
-44% -$187 ﹤0.01% 803
2025
Q3 		$388 Sell
9
-1
-10% -$39 ﹤0.01% 783
2025
Q2 		$384 Sell
10
-1
-9% -$38 ﹤0.01% 733
2025
Q1 		$426 Sell
11
-604
-98% -$22.1K ﹤0.01% 730
2024
Q4 		$20.8K Buy
615
+593
+2,695% +$21.3K 0.01% 306
2024
Q3 		$899 Buy
22
+12
+120% +$491 ﹤0.01% 587
2024
Q2 		$385 Sell
10
-511
-98% -$21.5K ﹤0.01% 619
2024
Q1 		$22.3K Buy
521
+512
+5,689% +$21.1K 0.01% 252
2023
Q4 		$334 Buy
+9
New +$323 ﹤0.01% 537

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Rakuten Securities's GSK Position: Q2 2026 in Review

Rakuten Securities increased its GSK (GSK) stake by 20% in Q2 2026, buying an estimated $53 and bringing the position to 6 shares worth $315. The position accounts for ﹤0.01% of the portfolio, ranked #807.

Rakuten Securities first reported a position in GSK in Q4 2023 and has held it in 11 quarters since. The position peaked at $22.3K in Q1 2024. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Rakuten Securities held 6 shares of GSK worth $315 as of Q2 2026.
  • Rakuten Securities bought 1 GSK share in Q2 2026, an estimated $53.
  • GSK made up ﹤0.01% of Rakuten Securities's portfolio in Q2 2026, its #807 holding.
  • Rakuten Securities first reported a position in GSK in Q4 2023 and has held it in 11 quarters since.
  • Rakuten Securities's GSK position peaked at $22.3K in Q1 2024.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.